The BH3-only Bim protein is a major determinant for initiating the intrinsic apoptotic pathway under both physiological and pathophysiological conditions. Tight regulation of its …
A Wiestner - Blood, The Journal of the American Society of …, 2012 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is a malignancy of mature B cells that depend on host factors in the tissue microenvironment for survival and proliferation. In vitro, CLL cells rapidly …
Abstract The Bcl-2 antagonist ABT-199 (venetoclax) has demonstrated promising clinical activity in patients with chronic lymphocytic leukemia (CLL). ABT-199 is strongly cytotoxic …
G Packham, S Krysov, A Allen, N Savelyeva… - …, 2014 - ncbi.nlm.nih.gov
Biologists and clinicians agree that the B-cell receptor influences the behavior of chronic lymphocytic leukemia, and promising new drugs are aimed at receptor-associated kinases …
B cell receptor (BCR) signaling is a central pathway promoting the survival and proliferation of normal and malignant B cells. Chronic lymphocytic leukemia (CLL) arises from mature B …
JC Godbersen, LA Humphries, OV Danilova… - Clinical cancer …, 2014 - AACR
Background: Stromal-mediated signaling enhances NF-κB pathway activity in chronic lymphocytic leukemia (CLL) B cells, leading to cell survival and chemoresistance …
MS Davids, J Deng, A Wiestner… - Blood, The Journal …, 2012 - ashpublications.org
Stroma induces treatment resistance in chronic lymphocytic leukemia (CLL), possibly because of alterations in the BCL-2 family of proteins, which are key regulators of apoptosis …
Duvelisib, an oral dual inhibitor of PI3K-δ and PI3K-γ, is in phase III trials for the treatment of chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin's lymphoma. In CLL …
R Gogada, N Yadav, J Liu, S Tang, D Zhang… - Journal of Biological …, 2013 - ASBMB
Proapoptotic Bcl-2 homology 3-only protein Bim plays an important role in Bax/Bak- mediated cytochrome c release and apoptosis. Here, we provide evidence for a novel …